356 related articles for article (PubMed ID: 28900159)
1. Computational Cell Cycle Profiling of Cancer Cells for Prioritizing FDA-Approved Drugs with Repurposing Potential.
Lo YC; Senese S; France B; Gholkar AA; Damoiseaux R; Torres JZ
Sci Rep; 2017 Sep; 7(1):11261. PubMed ID: 28900159
[TBL] [Abstract][Full Text] [Related]
2. Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDA-approved compounds.
Carrella D; Manni I; Tumaini B; Dattilo R; Papaccio F; Mutarelli M; Sirci F; Amoreo CA; Mottolese M; Iezzi M; Ciolli L; Aria V; Bosotti R; Isacchi A; Loreni F; Bardelli A; Avvedimento VE; di Bernardo D; Cardone L
Oncotarget; 2016 Sep; 7(37):58743-58758. PubMed ID: 27542212
[TBL] [Abstract][Full Text] [Related]
3. A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants.
Trombetta RP; Dunman PM; Schwarz EM; Kates SL; Awad HA
mSphere; 2018 Oct; 3(5):. PubMed ID: 30381352
[TBL] [Abstract][Full Text] [Related]
4. Large-Scale Off-Target Identification Using Fast and Accurate Dual Regularized One-Class Collaborative Filtering and Its Application to Drug Repurposing.
Lim H; Poleksic A; Yao Y; Tong H; He D; Zhuang L; Meng P; Xie L
PLoS Comput Biol; 2016 Oct; 12(10):e1005135. PubMed ID: 27716836
[TBL] [Abstract][Full Text] [Related]
5. Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.
Di J; Zheng B; Kong Q; Jiang Y; Liu S; Yang Y; Han X; Sheng Y; Zhang Y; Cheng L; Han J
Mol Oncol; 2019 Oct; 13(10):2259-2277. PubMed ID: 31408580
[TBL] [Abstract][Full Text] [Related]
6. From malaria to cancer: Computational drug repositioning of amodiaquine using PLIP interaction patterns.
Salentin S; Adasme MF; Heinrich JC; Haupt VJ; Daminelli S; Zhang Y; Schroeder M
Sci Rep; 2017 Sep; 7(1):11401. PubMed ID: 28900272
[TBL] [Abstract][Full Text] [Related]
7. Prioritizing therapeutics for lung cancer: an integrative meta-analysis of cancer gene signatures and chemogenomic data.
Fortney K; Griesman J; Kotlyar M; Pastrello C; Angeli M; Sound-Tsao M; Jurisica I
PLoS Comput Biol; 2015 Mar; 11(3):e1004068. PubMed ID: 25786242
[TBL] [Abstract][Full Text] [Related]
8. A Computational Bipartite Graph-Based Drug Repurposing Method.
Zheng S; Ma H; Wang J; Li J
Methods Mol Biol; 2019; 1903():115-127. PubMed ID: 30547439
[TBL] [Abstract][Full Text] [Related]
9. Pathway-Based Drug Repositioning for Cancers: Computational Prediction and Experimental Validation.
Iwata M; Hirose L; Kohara H; Liao J; Sawada R; Akiyoshi S; Tani K; Yamanishi Y
J Med Chem; 2018 Nov; 61(21):9583-9595. PubMed ID: 30371064
[TBL] [Abstract][Full Text] [Related]
10. DeSigN: connecting gene expression with therapeutics for drug repurposing and development.
Lee BK; Tiong KH; Chang JK; Liew CS; Abdul Rahman ZA; Tan AC; Khang TF; Cheong SC
BMC Genomics; 2017 Jan; 18(Suppl 1):934. PubMed ID: 28198666
[TBL] [Abstract][Full Text] [Related]
11. Repurposing of phentolamine as a potential anticancer agent against human castration-resistant prostate cancer: A central role on microtubule stabilization and mitochondrial apoptosis pathway.
Ho CH; Hsu JL; Liu SP; Hsu LC; Chang WL; Chao CC; Guh JH
Prostate; 2015 Sep; 75(13):1454-66. PubMed ID: 26180030
[TBL] [Abstract][Full Text] [Related]
12. A new computational drug repurposing method using established disease-drug pair knowledge.
Saberian N; Peyvandipour A; Donato M; Ansari S; Draghici S
Bioinformatics; 2019 Oct; 35(19):3672-3678. PubMed ID: 30840053
[TBL] [Abstract][Full Text] [Related]
13. Computational repositioning and preclinical validation of mifepristone for human vestibular schwannoma.
Sagers JE; Brown AS; Vasilijic S; Lewis RM; Sahin MI; Landegger LD; Perlis RH; Kohane IS; Welling DB; Patel CJ; Stankovic KM
Sci Rep; 2018 Apr; 8(1):5437. PubMed ID: 29615643
[TBL] [Abstract][Full Text] [Related]
14. A tool to utilize adverse effect profiles to identify brain-active medications for repurposing.
McCoy TH; Perlis RH
Int J Neuropsychopharmacol; 2015 Feb; 18(3):. PubMed ID: 25673184
[TBL] [Abstract][Full Text] [Related]
15. Exploring the selectivity of guanine scaffold in anticancer drug development by computational repurposing approach.
Sherin DR; Manojkumar TK
Sci Rep; 2021 Aug; 11(1):16251. PubMed ID: 34376738
[TBL] [Abstract][Full Text] [Related]
16. Predicting new indications for approved drugs using a proteochemometric method.
Dakshanamurthy S; Issa NT; Assefnia S; Seshasayee A; Peters OJ; Madhavan S; Uren A; Brown ML; Byers SW
J Med Chem; 2012 Aug; 55(15):6832-48. PubMed ID: 22780961
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
Wang Y; Yella J; Jegga AG
Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
[TBL] [Abstract][Full Text] [Related]
18. Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment.
Nagaraj AB; Wang QQ; Joseph P; Zheng C; Chen Y; Kovalenko O; Singh S; Armstrong A; Resnick K; Zanotti K; Waggoner S; Xu R; DiFeo A
Oncogene; 2018 Jan; 37(3):403-414. PubMed ID: 28967908
[TBL] [Abstract][Full Text] [Related]
19. ANTENNA, a Multi-Rank, Multi-Layered Recommender System for Inferring Reliable Drug-Gene-Disease Associations: Repurposing Diazoxide as a Targeted Anti-Cancer Therapy.
Wang A; Lim H; Cheng SY; Xie L
IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(6):1960-1967. PubMed ID: 29993812
[TBL] [Abstract][Full Text] [Related]
20. An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs.
Bhattarai D; Singh S; Jang Y; Hyeon Han S; Lee K; Choi Y
Curr Top Med Chem; 2016; 16(19):2156-68. PubMed ID: 26881715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]